< Back
Coated tablets
Strength and Package description:
10 mg - x 30 and 60 tablets
20 mg - x 30 and 60 tablets
40 mg - x 30 tablets
Therapeutic category: LIPID MODIFYING AGENTS
Therapeutic action: HMG-Co-A reductase inhibitor

capsules
Strength and Package description:
200 mg - x 30 and 60 caps
Therapeutic category: LIPID MODIFYING AGENTS
Therapeutic action: Fibrate. Indicated in hypertriglyceridemia

Coated tablets
Strength and Package description:
10 mg - x 28 and 30 tablets
20 mg - x 28 and 30 tablets
40 mg - x 28 tablets
Therapeutic category: LIPID MODIFYING AGENTS
Therapeutic action: HMG-Co-A reductase inhibitor

ATORVASTATIN RICHET
AtorvastatinCoated tablets
Strength and Package description:
10 mg - x 30 and 60 tablets
20 mg - x 30 and 60 tablets
40 mg - x 30 tablets
Therapeutic category: LIPID MODIFYING AGENTS
Therapeutic action: HMG-Co-A reductase inhibitor

FENOFIBRATO RICHET
Fenofibrate, micronisedcapsules
Strength and Package description:
200 mg - x 30 and 60 caps
Therapeutic category: LIPID MODIFYING AGENTS
Therapeutic action: Fibrate. Indicated in hypertriglyceridemia

ROSUVASTATINA RICHET
RosuvastatinCoated tablets
Strength and Package description:
10 mg - x 28 and 30 tablets
20 mg - x 28 and 30 tablets
40 mg - x 28 tablets
Therapeutic category: LIPID MODIFYING AGENTS
Therapeutic action: HMG-Co-A reductase inhibitor